Lexpos News

MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection Drug Alert Number: EL(25)A/08 Date issued: 03 March 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection DMRC reference [...]

The post MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Desmopressin 10microgram/dose nasal spray MSN/2025/010 Tier 2 medium impact Date of issue: 3rd March 2025 Desmopressin 10microgram/dose nasal spray is out of stock with an anticipated re-supply date of early September 2025. Unlicensed supplies of desmopressin 10microgram/dose nasal spray are available, [...]

The post Medicine Supply Notification: Desmopressin 10microgram/dose nasal spray appeared first on Community Pharmacy England.

A high percentage of disallowed items are appliances or chemical reagents not listed in Part IX (the Appliances section) of the Drug Tariff or products ordered by dentists or community nurse prescribers which are not listed in their respective formularies. Recently, Community Pharmacy England has received queries from pharmacy owners concerned about the losses incurred [...]

The post Dispensing disallowed items appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (28/02/2025) announced the following list of price concessions for February 2025: This is not the final update for February. We are still working with the DHSC to agree [...]

The post February 2025 Price Concessions 4th Update appeared first on Community Pharmacy England.

Viatris UK has announced that, from 1 March 2025, all orders of licensed Creon® preparations should be placed directly with Alliance Healthcare UK. This is a shift away from the current three-wholesaler (AAH, Alliance Healthcare UK and Phoenix) distribution model to using only Alliance Healthcare UK as the sole distributor of licensed Creon® preparations in [...]

The post Change to Creon® distribution arrangements from 1 March 2025 appeared first on Community Pharmacy England.